Submit your email to push it up the queue
Met-Rx Substrate Technology, Inc., headquartered in the United States, is a leading innovator in the nutritional supplement industry. Founded in the early 1990s, the company has established itself as a pioneer in formulating high-quality protein products and performance-enhancing supplements. With a focus on research and development, Met-Rx has introduced unique offerings such as their proprietary protein blends and advanced meal replacement solutions. The company operates primarily in North America, catering to fitness enthusiasts and athletes seeking optimal nutrition. Met-Rx's commitment to quality and efficacy has earned it a strong market position, recognised for its scientifically-backed formulations. Notable achievements include numerous industry awards and a loyal customer base that values the brand's dedication to performance and health.
How does Met-Rx Substrate Technology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Met-Rx Substrate Technology, Inc.'s score of 15 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Met-Rx Substrate Technology, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of The Bountiful Company, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Met-Rx Substrate Technology, Inc., it is important to note that emissions data and sustainability initiatives may be inherited from its parent company. The Bountiful Company, as the source organization, may have its own climate strategies and targets that could impact Met-Rx's environmental performance. As of now, Met-Rx Substrate Technology, Inc. has not established specific science-based targets or commitments to reduce emissions, which places it in a broader context of industry practices where many companies are increasingly focusing on sustainability and carbon neutrality. The absence of specific data highlights the need for enhanced transparency and commitment to climate action within the organisation.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Met-Rx Substrate Technology, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.